NCT02203981View on ClinicalTrials.gov

TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy
Trial Locations (1)

07436

Topcon Medical Systems, Inc., Oakland

All Listed Sponsors
lead

Topcon Medical Systems, Inc.

INDUSTRY

NCT02203981 - TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000 | Biotech Hunter | Biotech Hunter